HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yufan Gu Selected Research
Yufan Gu Research Topics
Disease
2
Fibrosis (Cirrhosis)
12/2023 - 01/2023
1
Vascular Remodeling
12/2023
1
Hypertrophy
12/2023
1
Hypertension (High Blood Pressure)
12/2023
1
Pulmonary Arterial Hypertension
01/2023
1
Iron Overload
01/2020
1
Necrosis
01/2020
1
Osteoporosis
01/2020
1
Autoimmune Diseases (Autoimmune Disease)
02/2019
1
Melanoma (Melanoma, Malignant)
11/2017
1
Neoplasms (Cancer)
11/2017
1
Abnormal Reflex (Hyperreflexia)
11/2017
1
Guillain-Barre Syndrome
11/2017
Drug/Important Bio-Agent (IBA)
2
Proteins (Proteins, Gene)
FDA Link
12/2023 - 01/2023
1
Verteporfin (Visudyne)
FDA Link
12/2023
1
rho-Associated Kinases
IBA
12/2023
1
fasudil (AT 877)
IBA
12/2023
1
Mitogen-Activated Protein Kinase 3
IBA
12/2023
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
12/2023
1
Angiotensin II
IBA
12/2023
1
Collagen
IBA
12/2023
1
2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- one
IBA
12/2023
1
68Ga-FAPI
IBA
01/2023
1
Annexin A5
IBA
01/2020
1
Acetylcysteine (Siran)
FDA Link
Generic
01/2020
1
Mitochondrial Permeability Transition Pore
IBA
01/2020
1
Iron
IBA
01/2020
1
1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
IBA
01/2020
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
01/2020
1
Bisbenzimidazole (Hoechst 33258)
IBA
01/2020
1
B-Cell Activating Factor
IBA
02/2019
1
Epoxy Compounds (Epoxides)
IBA
02/2019
1
Autoantibodies
IBA
02/2019
1
Ipilimumab
IBA
11/2017
1
Nivolumab
IBA
11/2017
Therapy/Procedure
1
Immunotherapy
11/2017
1
Therapeutics
11/2017